Found: 12
Select item for more details and to access through your institution.
Impact of bioprosthetic valve type on peri-procedural myocardial injury and mortality after transcatheter aortic valve replacement.
- Published in:
- Heart & Vessels, 2021, v. 36, n. 11, p. 1746, doi. 10.1007/s00380-021-01861-8
- By:
- Publication type:
- Article
The role of prehabilitation in HNSCC patients treated with chemoradiotherapy.
- Published in:
- Supportive Care in Cancer, 2024, v. 32, n. 10, p. 1, doi. 10.1007/s00520-024-08834-3
- By:
- Publication type:
- Article
Cardiac effects of deferasirox in transfusion‐dependent patients with myelodysplastic syndromes: TELESTO study.
- Published in:
- British Journal of Haematology, 2024, v. 204, n. 5, p. 2049, doi. 10.1111/bjh.19316
- By:
- Publication type:
- Article
Potential of creatine or phosphocreatine supplementation in cerebrovascular disease and in ischemic heart disease.
- Published in:
- Amino Acids, 2016, v. 48, n. 8, p. 1955, doi. 10.1007/s00726-016-2173-8
- By:
- Publication type:
- Article
How to Monitor Cardiac Complications of Immune Checkpoint Inhibitor Therapy.
- Published in:
- Frontiers in Pharmacology, 2020, v. 11, p. 1, doi. 10.3389/fphar.2020.00972
- By:
- Publication type:
- Article
An increase in myocardial 18-fluorodeoxyglucose uptake is associated with left ventricular ejection fraction decline in Hodgkin lymphoma patients treated with anthracycline.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Potential cardiac risk of immune‐checkpoint blockade as anticancer treatment: What we know, what we do not know, and what we can do to prevent adverse effects.
- Published in:
- Medicinal Research Reviews, 2018, v. 38, n. 5, p. 1447, doi. 10.1002/med.21478
- By:
- Publication type:
- Article
Ivabradine in Cancer Treatment-Related Left Ventricular Dysfunction.
- Published in:
- Chemotherapy (0009-3157), 2018, v. 63, n. 6, p. 315, doi. 10.1159/000495576
- By:
- Publication type:
- Article
Cardiovascular risk profile and events before and after treatment with anti-VEGF drugs in the setting of a structured cardio-oncologic program.
- Published in:
- European Journal of Preventive Cardiology, 2021, v. 28, n. 9, p. e38, doi. 10.1177/2047487320923056
- By:
- Publication type:
- Article
Doxorubicin Effect on Myocardial Metabolism as a Prerequisite for Subsequent Development of Cardiac Toxicity: A Translational <sup>18</sup>F-FDG PET/CT Observation.
- Published in:
- Journal of Nuclear Medicine, 2017, v. 58, n. 10, p. 1638, doi. 10.2967/jnumed.117.191122
- By:
- Publication type:
- Article
A Score-Based Approach to <sup>18</sup>F-FDG PET Images as a Tool to Describe Metabolic Predictors of Myocardial Doxorubicin Susceptibility.
- Published in:
- Diagnostics (2075-4418), 2017, v. 7, n. 4, p. 57, doi. 10.3390/diagnostics7040057
- By:
- Publication type:
- Article
Serial Troponin for Early Detection of Nivolumab Cardiotoxicity in Advanced Non‐Small Cell Lung Cancer Patients.
- Published in:
- Oncologist, 2018, v. 23, n. 8, p. 936, doi. 10.1634/theoncologist.2017-0452
- By:
- Publication type:
- Article